EUVIMEDEUVIMED entdecken
Open Access

Single in situ intratumoral low‑dose shikonin hydrogel plus mild photothermal therapy elicits systemic antitumor immunity in immune‑cold triple‑negative breast cancer

Tao Pan, Zujian Feng, Ting Shang, Jun Jiang, Fang Zhang

International Journal of Oncology · 2026

DOI: 10.3892/ijo.2026.5930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oncology, 2026. Verfasst von Tao Pan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China. Hauptthemen laut MEDLINE: Naphthoquinones, Triple Negative Breast Neoplasms, Photothermal Therapy. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shikonin (SHK) possesses potent antitumor activity; however, its severe non‑selective toxicity greatly limits the feasibility of conventional systemic administration for cancer therapy. Likewise, mild photothermal therapy (PTT) has intrinsic limitations, including inadequate induction of immunogenic cell death (ICD) and compensatory activation of immunosuppressive pathways, such as increased IDO1 activity and PD‑L1 expression. In the present study, low‑dose SHK and gold nanorods were co‑encapsulated within a supramolecular hydrogel (mPECT) and administered by intratumoral injection to achieve localized combination therapy with mild PTT. Mild PTT rapidly triggered antitumor immune activation within the immunosuppressive tumor microenvironment, whereas SHK sustained this response by suppressing PTT‑induced IDO1 activation and PD‑L1 upregulation and by markedly enhancing ICD. The mPECT hydrogel enabled prolonged local retention and controlled release of SHK, minimizing rapid systemic exposure while preserving therapeutic efficacy at the tumor site. This localized combination of SHK and mild PTT elicited a robust adaptive antitumor immune response that not only inhibited primary tumor growth but also suppressed the progression of untreated distant tumors and generated durable antitumor immune memory. These findings indicate that a single intratumoral administration of low‑dose SHK‑loaded hydrogel combined with mild PTT can induce potent systemic antitumor immunity, supporting the further development of localized SHK‑based therapeutic strategies for the treatment of immune‑cold tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaphthoquinonesTriple Negative Breast NeoplasmsPhotothermal TherapyAnimalsFemaleHumansMiceCell Line, TumorTumor MicroenvironmentHydrogelsXenograft Model Antitumor AssaysInjections, IntralesionalGoldCombined Modality TherapyNanotubes

Stichwörter der Autor:innen

IDO1PD‑L1SHKTNBCabscopal effecthydrogelimmune memoryimmunogenic cell deathintratumoral administrationmild PTT

Substanzen

shikoninNaphthoquinonesHydrogelsGold

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China.
  • Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, P.R. China.
  • Department of Health Service, Air Force Medical University, Xi'an, Shaanxi 710032, P.R. China.
  • The Second Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi 710038, P.R. China.

Zitieren

APA

Pan, T., Feng, Z., Shang, T., Jiang, J., & Zhang, F. (2026). Single in situ intratumoral low‑dose shikonin hydrogel plus mild photothermal therapy elicits systemic antitumor immunity in immune‑cold triple‑negative breast cancer. International Journal of Oncology. https://doi.org/10.3892/ijo.2026.5930

Vancouver

Pan T, Feng Z, Shang T, Jiang J, Zhang F. Single in situ intratumoral low‑dose shikonin hydrogel plus mild photothermal therapy elicits systemic antitumor immunity in immune‑cold triple‑negative breast cancer. International Journal of Oncology. 2026. doi:10.3892/ijo.2026.5930

BibTeX
@article{Pan2026,
  author = {Pan, Tao and Feng, Zujian and Shang, Ting and Jiang, Jun and Zhang, Fang},
  title = {Single in situ intratumoral low‑dose shikonin hydrogel plus mild photothermal therapy elicits systemic antitumor immunity in immune‑cold triple‑negative breast cancer},
  journal = {International Journal of Oncology},
  year = {2026},
  doi = {10.3892/ijo.2026.5930}
}
Kostenlos starten →